一、前言 近年来，随着干细胞治疗、免疫细胞治疗和基因编辑等基础理论、技术手段和临床医疗探索研究的不断发展，细胞治疗产品为一些严重及难治性疾病提供...

1.制定发布《细胞治疗产品研究与评价技术指导原则》的背景是什么？ 细胞治疗技术是目前国际医学前沿重点发展领域，它给一些人类疑难疾病的治疗提供了新...

Emerging immuno-oncology player Tessa Therapeutics has raised $80 millio...

WALTHAM, Mass.,Dec. 20, 2017/PRNewswire/ -- Juno Therapeutics (NASDAQ:JU...

The blood-brain barrier disruption appears to be “a unique mechanism wit...

PHILADELPHIA,Nov. 17, 2017/PRNewswire/ -- WuXi AppTec (WuXi), a leading ...

Seattle Children’s has opened the first chimeric antigen receptor (CAR) ...

The Food and Drug Administration (FDA) has approved Gazyva (obinutuzumab...

The FDA has granted Bluebird bb2121 a breakthrough therapy designation f...